C4 Therapeutics, Inc. (CCCC) SEC Filings — 2025
12 SEC filings for C4 Therapeutics, Inc. (CCCC) in 2025.
Filings
- C4 Therapeutics' Losses Widen Amid Revenue Dip, Asset Impairment — 10-Q · Nov 6, 2025
- C4 Therapeutics Files 8-K: Material Agreement & Exhibits — 8-K · Oct 16, 2025
- C4 Therapeutics Files 8-K: Other Events Reported — 8-K · Oct 16, 2025
- C4 Therapeutics Files 8-K — 8-K · Oct 1, 2025
- C4 Therapeutics Files 8-K on Sept 22 — 8-K · Sep 22, 2025
- C4 Therapeutics' Q2 Net Loss Widens to $48.2M Amid R&D Push — 10-Q · Aug 7, 2025
- C4 Therapeutics Files 8-K on Corporate Governance — 8-K · Jun 18, 2025
- C4 Therapeutics Files Q1 2025 10-Q — 10-Q · May 7, 2025
- C4 Therapeutics Files DEF 14A on Executive Compensation — DEF 14A · Apr 29, 2025
- C4 Therapeutics Appoints New Chief Medical Officer — 8-K · Apr 14, 2025
- C4 Therapeutics, Inc. 10-K Filing — 10-K · Feb 27, 2025
- C4 Therapeutics Files 8-K on Operations and Finance — 8-K · Jan 14, 2025